Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Journal of clinical oncology

Results: 1-25/682

Authors: Goodwin, PJ
Citation: Pj. Goodwin, Weight gain in early-stage breast cancer: Where do we go from here?, J CL ONCOL, 19(9), 2001, pp. 2367-2369

Authors: Kirkwood, JM Ibrahim, JG Sosman, JA Sondak, VK Agarwala, SS Ernstoff, MS Rao, U
Citation: Jm. Kirkwood et al., High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: Results of Intergroup trial E1694/S9512/C509801, J CL ONCOL, 19(9), 2001, pp. 2370-2380

Authors: Demark-Wahnefried, W Peterson, BL Winer, EP Marks, L Aziz, N Marcom, PK Blackwell, K Rimer, BK
Citation: W. Demark-wahnefried et al., Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy, J CL ONCOL, 19(9), 2001, pp. 2381-2389

Authors: Kobrinsky, NL Sposto, R Shah, NR Anderson, JR DeLaat, C Morse, M Warkentin, P Gilchrist, GS Cohen, MD Shina, D Meadows, AT
Citation: Nl. Kobrinsky et al., Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and L-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group study CCG-5912, J CL ONCOL, 19(9), 2001, pp. 2390-2396

Authors: Dalle, JH Mechinaud, F Michon, J Gentet, JC de Lumley, L Rubie, H Schmitt, C Patte, C
Citation: Jh. Dalle et al., Testicular disease in childhood B-cell non-Hodgkin's lymphoma: The French Society of Pediatric Oncology experience, J CL ONCOL, 19(9), 2001, pp. 2397-2403

Authors: Copur, MS Capadano, M Lynch, J Goertzen, T McCowan, T Brand, R Tempero, M
Citation: Ms. Copur et al., Alternating hepatic arterial infusion and systemic chemotherapy for liver metastases from colorectal cancer: A phase II trial using intermittent percutaneous hepatic arterial access, J CL ONCOL, 19(9), 2001, pp. 2404-2412

Authors: O'Dwyer, PJ Manola, J Valone, FH Ryan, LM Hines, JD Wadler, S Haller, DG Arbuck, SG Weiner, LM Mayer, RJ Benson, AB
Citation: Pj. O'Dwyer et al., Fluorouracil modulation in colorectal cancer: Lack of improvement with N-phosphonoacetyl-l-aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule - An Eastern Cooperative Oncology Group/Cancer and Leukemia Group B study, J CL ONCOL, 19(9), 2001, pp. 2413-2421

Authors: Friess, H Guo, XZ Tempia-Caliera, AA Fukuda, A Martignoni, ME Zimmermann, A Korc, M Buchler, MW
Citation: H. Friess et al., Differential expression of metastasis-associated genes in papilla of vaterand pancreatic cancer correlates with disease stage, J CL ONCOL, 19(9), 2001, pp. 2422-2432

Authors: Freyer, G Bossard, N Romestaing, P Mornex, F Chapet, O Trillet-Lenoir, V Gerard, JP
Citation: G. Freyer et al., Addition of oxaliplatin to continuous fluorouracil, L-folinic acid, and concomitant radiotherapy in rectal cancer: The Lyon R 97-03 Phase I trial, J CL ONCOL, 19(9), 2001, pp. 2433-2438

Authors: Paltiel, O Avitzour, M Peretz, T Cherny, N Kaduri, L Pfeffer, RM Wagner, N Soskolne, V
Citation: O. Paltiel et al., Determinants of the use of complementary therapies by patients with cancer, J CL ONCOL, 19(9), 2001, pp. 2439-2448

Authors: Chinot, OL Honore, S Dufour, H Barrie, M Figarella-Branger, D Muracciole, X Braguer, D Martin, PM Grisoli, F
Citation: Ol. Chinot et al., Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy, J CL ONCOL, 19(9), 2001, pp. 2449-2455

Authors: Duvic, M Hymes, K Heald, P Breneman, D Martin, AG Myskowski, P Crowley, C Yocum, RC
Citation: M. Duvic et al., Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: Multinational phase II-III trial results, J CL ONCOL, 19(9), 2001, pp. 2456-2471

Authors: Lillington, DM Micallef, INM Carpenter, E Neat, MJ Amess, JAL Matthews, J Foot, NJ Young, BD Lister, TA Rohatiner, AZS
Citation: Dm. Lillington et al., Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma, J CL ONCOL, 19(9), 2001, pp. 2472-2481

Authors: Mrozek, K Prior, TW Edwards, C Marcucci, G Carroll, AJ Snyder, PJ Koduru, PRK Theil, KS Pettenati, MJ Archer, KJ Caligiuri, MA Vardiman, JW Kolitz, JE Larson, RA Bloomfield, CD
Citation: K. Mrozek et al., Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: A cancer and leukemia group B study, J CL ONCOL, 19(9), 2001, pp. 2482-2492

Authors: Hidalgo, M Aylesworth, C Hammond, LA Britten, CD Weiss, G Stephenson, J Schwartz, G Patnaik, A Smith, L Molpus, K Felton, S Gupta, E Ferrante, KJ Tortora, A Sonnichsen, DS Skillings, J Rowinsky, EK
Citation: M. Hidalgo et al., Phase I and pharmacokinetic study of BMS-184476, a taxane with greater potency and solubility than paclitaxel, J CL ONCOL, 19(9), 2001, pp. 2493-2503

Authors: Tucker, R Coel, M Ko, J Morris, P Druger, G McGuigan, P
Citation: R. Tucker et al., Impact of fluorine-18 fluorodeoxyglucose positron emission tomography on patient management: First year's experience in a clinical center, J CL ONCOL, 19(9), 2001, pp. 2504-2508

Authors: Savarese, DM Halabi, S Hars, V Akerley, WL Taplin, ME Godley, PA Hussain, A Small, EJ Vogelzang, NJ
Citation: Dm. Savarese et al., Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: A final report of CALGB 9780, J CL ONCOL, 19(9), 2001, pp. 2509-2516

Authors: Hamilton, AS Stanford, JL Gilliland, FD Albertsen, PC Stephenson, RA Hoffman, RM Eley, JW Harlan, LC Potosky, AL
Citation: As. Hamilton et al., Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: Results from the Prostate Cancer Outcomes study, J CL ONCOL, 19(9), 2001, pp. 2517-2526

Authors: Hussain, M Vaishampayan, U Du, W Redman, B Smith, DC
Citation: M. Hussain et al., Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer, J CL ONCOL, 19(9), 2001, pp. 2527-2533

Authors: Mazumdar, M Bajorin, DF Bacik, J Higgins, G Motzer, RJ Bosl, GJ
Citation: M. Mazumdar et al., Predicting outcome to chemotherapy in patients with germ cell tumors: The value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy, J CL ONCOL, 19(9), 2001, pp. 2534-2541

Authors: Cherny, N Ripamonti, C Pereira, J Davis, C Fallon, M McQuay, H Mercadante, S Pasternak, G Ventafridda, V
Citation: N. Cherny et al., Strategies to manage the adverse effects of oral morphine: An evidence-based report, J CL ONCOL, 19(9), 2001, pp. 2542-2554

Authors: Peshkin, BN DeMarco, TA Brogan, BM Lerman, C Isaacs, C
Citation: Bn. Peshkin et al., BRCA1/2 testing: Complex themes in result interpretation, J CL ONCOL, 19(9), 2001, pp. 2555-2565

Authors: Jefford, M Phillips, KA Tattersall, MHN
Citation: M. Jefford et al., An online educational facility for medical oncology trainees: www.vmotg.org, J CL ONCOL, 19(9), 2001, pp. 2566-2569

Authors: Mansouri, H Jalil, A Choho, L Souadka, A El Gueddari, B
Citation: H. Mansouri et al., Unusual aspects of breast cancer - Case 1. Angiosarcoma of the breast, J CL ONCOL, 19(9), 2001, pp. 2570-2571

Authors: Burstein, HJ Swanson, SJ Christian, RL McMenamin, ME
Citation: Hj. Burstein et al., Unusual aspects of breast cancer - Case 2. Synchronous bilateral lung and breast cancers, J CL ONCOL, 19(9), 2001, pp. 2571-2573
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>